PET scan reveals best time for Alzheimer’s drug trials

A group from Montreal, Quebec studied the activity of the amyloid PET radiotracer in PET brain scans of a large group of patients with Alzheimer’s disease enrolled in clinical trials. The team found significant early activity in most patients considered negative for the disease and suggests moving the starting gate when it comes to testing …

PET scan reveals best time for Alzheimer’s drug trials Read More »